The Rising Influx of Multidrug-Resistant Gram-Negative Bacilli into a Tertiary Care Hospital
Open Access
- 15 June 2005
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 40 (12) , 1792-1798
- https://doi.org/10.1086/430314
Abstract
Background. The prevalence of multidrug resistance (MDR) among gram-negative bacilli is rapidly increasing. Quantification of the prevalence and the common antimicrobial coresistance patterns of MDR gram-negative bacilli (MDR-GNB) isolates recovered from patients at hospital admission, as well as identification of patients with a high risk of harboring MDR-GNB, would have important implications for patient care. Methods. Over a 6-year period, patients who harbored MDR-GNB (i.e., patients who had MDR-GNB isolates recovered from clinical cultures within the first 48 h after hospital admission) were identified. “MDR-GNB isolates” were defined asPseudomonas aeruginosa, Escherichia coli, Enterobacter cloacae, andKlebsiella species isolates with resistance to at least 3 antimicrobial groups. A case-control study was performed to determine the independent risk factors for harboring MDR-GNB at hospital admission. Results. Between 1998 and 2003, the prevalence of MDR-GNB isolates recovered from patients at hospital admission increased significantly for all isolate species (P < .001), with the exception ofP. aeruginosa (P = .09). Of 464 MDR-GNB isolates, 12%, 35%, and 53% of isolates were coresistant to 5, 4, and 3 antimicrobial groups, respectively. Multivariable analysis identified age ⩾65 years (odds ratio [OR], 2.8; 95% confidence interval [CI], 1.1–7.4;P < .04), prior exposure to antibiotics for ⩾14 days (OR, 8.7; 95% CI, 2.5 –30;P < .001), and prior residence in a long-term care facility (OR, 3.5; 95% CI, 1.3–9.4;P < .01) as independent risk factors for harboring MDR-GNB at hospital admission. Conclusion. A substantial number of patients harbor MDR-GNB at hospital admission. Identification of common coresistance patterns among MDR-GNB isolates may assist in the selection of empirical antimicrobial therapy for patients with a high risk of harboring MDR-GNB.Keywords
This publication has 25 references indexed in Scilit:
- Rapidly Rising Prevalence of Nosocomial Multidrug-Resistant, Gram-Negative Bacilli: A 9-Year Surveillance StudyInfection Control, 2004
- Preventing the Influx of Vancomycin‐Resistant Enterococci into Health Care Institutions, by Use of a Simple Validated Prediction RuleClinical Infectious Diseases, 2004
- Methicillin-resistant Staphylococcus aureus bacteraemia diagnosed at hospital admission: distinguishing between community-acquired versus healthcare-associated strainsJournal of Antimicrobial Chemotherapy, 2004
- Pseudomonas aeruginosaBacteremia: Risk Factors for Mortality and Influence of Delayed Receipt of Effective Antimicrobial Therapy on Clinical OutcomeClinical Infectious Diseases, 2003
- Surveillance for Antimicrobial Susceptibility among Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from Hospitalized Patients in the United States, 1998 to 2001Antimicrobial Agents and Chemotherapy, 2003
- Trends in Antimicrobial Susceptibilities among Enterobacteriaceae Isolated from Hospitalized Patients in the United States from 1998 to 2001Antimicrobial Agents and Chemotherapy, 2003
- Clinical Prevalence, Antimicrobial Susceptibility, and Geographic Resistance Patterns of Enterococci: Results from the SENTRY Antimicrobial Surveillance Program, 1997–1999Clinical Infectious Diseases, 2001
- Extended-Spectrum -Lactamase-Producing Escherichia coli and Klebsiella pneumoniae: Risk Factors for Infection and Impact of Resistance on OutcomesClinical Infectious Diseases, 2001
- Nosocomial Infections Caused by Multiresistant Pseudomonas aeruginosaInfection Control & Hospital Epidemiology, 1999
- The molecular and clinical epidemiology of enterobacteriaceae-producing extended-spectrum β-lactamase in a tertiary care hospitalJournal of Infection, 1998